AP
GMED icon

Antipodes Partners’s Globus Medical GMED Stock Holding History

Antipodes Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.6M Buy
905,984
+8,377
+0.9% +$712K 1.31% 38
2026
Q1 		$77.3M Sell
897,607
-9,226
-1% -$828K 1.49% 32
2025
Q4 		$79.2M Buy
906,833
+15,790
+2% +$1.2M 1.66% 27
2025
Q3 		$51M Buy
891,043
+889,229
+49,020% +$51.2M 1.15% 33
2025
Q2 		$107K Buy
1,814
+67
+4% +$4.33K ﹤0.01% 74
2025
Q1 		$128K Buy
+1,747
New +$144K ﹤0.01% 67

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Antipodes Partners's GMED Position: Q2 2026 in Review

Antipodes Partners increased its Globus Medical (GMED) stake by 0.93% in Q2 2026, buying an estimated $712K and bringing the position to 905,984 shares worth $71.6M. The position accounts for 1.31% of the portfolio, ranked #38.

Antipodes Partners first reported a position in GMED in Q1 2025 and has held it in 6 quarters since. The position peaked at $79.2M in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Antipodes Partners held 905,984 shares of Globus Medical worth $71.6M as of Q2 2026.
  • Antipodes Partners bought 8,377 Globus Medical shares in Q2 2026, an estimated $712K.
  • Globus Medical made up 1.31% of Antipodes Partners's portfolio in Q2 2026, its #38 holding.
  • Antipodes Partners first reported a position in Globus Medical in Q1 2025 and has held it in 6 quarters since.
  • Antipodes Partners's Globus Medical position peaked at $79.2M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.